Veeda Clinical Research Of India To Open Facility In Malaysia
This article was originally published in PharmAsia News
Executive SummaryIndia's Veeda Clinical Research plans to set up an advanced-research operation at a hospital in Malaysia by the end of the year to conduct Phase I drug tests. Veeda already has facilities in Belgium and the United Kingdom as well as India, so the Malaysia clinic would be its first in Southeast Asia. Veeda is India's fastest-growing organization conducting clinical research. (Click here for more
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.